Pacira Pharmaceuticals Inc recalls
Pacira Pharmaceuticals Inc is named on 2 recalls in Recall Relay's records since November 2023, from FDA; the most recent was June 12, 2024.
All 2, newest first.
-
Class IIofficial
Pacira Pharmaceuticals Inc recalls Zilretta (triamcinolone acetonide extended-release injectable suspension)Failed Dissolution Specifications - did not meet the acceptance criteria for IVR Level 3 testing at 9 months 2-8¿C followed by 6 weeks at 25¿C
-
Class IIofficial
Pacira Pharmaceuticals Inc recalls Drug Vial Label: Zilretta¿ (triamcinolone acetonide extended-release injectable suspension)Failed Stability Specifications - at 12 months 2-8 degrees C followed by 6 weeks at 25 degrees C.
This page groups recalls by the company name the agency printed, so it can include different companies with similar names, and a recall may name a store or distributor rather than the maker. It counts the recalls in Recall Relay's records, not a company's whole history; an FDA recall that lists several products counts once. Open a recall to see its details and the agency's official notice, which is always the final word. Recall Relay isn't affiliated with any agency or with the companies named here.
Severity labels say where they come from: “official” is the agency's own class, “advisory” is based on the agency's safety warning, and “est. risk” is Recall Relay's estimate from the hazard description, not an agency classification.
Hear about the next one
Recall Relay can email you when a new recall mentions Pacira Pharmaceuticals Inc or any words you choose. Start with a free key (no card needed), then set up alerts on your account page.
Get recall alerts